The global Treatment Resistant Depression Market is estimated to be valued at US$ 1,180.0 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Treatment-resistant depression refers to a condition where individuals do not respond adequately to traditional antidepressant treatments. This ... Read more
Treatment resistant depression refers to depression that does not respond to at least two antidepressant treatments of adequate dose and duration in the current episode. It is associated with serious functional impairment and increased medical costs. Patients suffering from treatment resistant depression opt for alternative therapies such as psychotherapy, somatic treatments including electroconvulsive therapy, and novel pharmacological therapies. The global Treatment Resistant ... Read more
Treatment resistant depression (TRD) refers to cases where individuals do not see adequate relief from depression even after multiple antidepressant medications or psychotherapies. It is estimated that up to one-third of individuals with major depressive disorder (MDD) will not have an adequate response to initial antidepressant therapy. Those with TRD often experience more chronic, severe and disabling forms of depression compared to non- ... Read more
